Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference
Rhea-AI Summary
Viatris (Nasdaq: VTRS) has announced its participation in two major healthcare conferences in November 2024. The company will attend the UBS Global Healthcare Conference on November 12 at the Terranea Resort in California, with a fireside chat scheduled for 8:45 a.m. PT. Additionally, Viatris will participate in the Jefferies London Healthcare Conference on November 21 at the Waldorf Hilton Hotel in London, with a session at 10:30 a.m. GMT.
Both events will feature fireside chats with Viatris executives and will be accessible via live webcasts at investor.viatris.com, with archived versions available for time after the events.
Positive
- None.
Negative
- None.
News Market Reaction – VTRS
In the trading session that priced this news, VTRS declined 0.17%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Details of the presentations can be found below:
UBS Global Healthcare Conference
- Date: Tuesday, November 12, 2024
- Time: 8:45 a.m. PT / 11:45 a.m. ET
- Location: Terranea Resort in
Rancho Palos Verdes, California - Format: Fireside chat with Viatris executives
Jeffries London Healthcare Conference
- Date: Thursday, November 21, 2024
- Time: 10:30 a.m. GMT / 5:30 a.m. ET
- Location: Waldorf Hilton Hotel in
London, England - Format: Fireside chat with Viatris executives
Interested parties can access live webcasts of both events at investor.viatris.com. An archived version also will be available following the live event and can be accessed at the same location for a limited time.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-participate-in-the-ubs-global-healthcare-conference-and-jefferies-london-healthcare-conference-302290043.html
SOURCE Viatris Inc.